Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents
Chemistry & Biodiversity · 2024-05 · 21 (5)
DOI: 10.1002/cbdv.202301399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 28.03.2024. Verfasst von Usman Ghani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Glycoside Hydrolase Inhibitors, alpha-Glucosidases, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Deputyship for Research and Innovation, "Ministry of Education" in Saudi Arabia.
Abstract (Originalsprache)
Imidazoles and phenylthiazoles are an important class of heterocycles that demonstrate a wide range of biological activities against various types of cancers, diabetes mellitus and pathogenic microorganisms. The heterocyclic structure having oxothiazolidine moiety is an important scaffold present in various drugs, with potential for enzyme inhibition. In an effort to discover new heterocyclic compounds, we synthesized 26 new 4,5‐diphenyl‐1 H ‐imidazole, phenylthiazole, and oxothiazolidine heterocyclic analogues that demonstrated potent α‐glucosidase inhibition and anticancer activities. Majority of the compounds noncompetitively inhibited α‐glucosidase except for two that exhibited competitive inhibition of the enzyme. Docking results suggested that the noncompetitive inhibitors bind to an apparent allosteric site on the enzyme located in the vicinity of the active site. Additionally, the analogues also exhibited significant activity against various types of cancers including non‐small lung cancer. Since tubulin protein plays an important role in the pathogenesis of non‐small lung cancer, molecular docking with one of the target compounds provided important clues to its binding mode. The current work on imidazoles and phenylthiazole derivatives bears importance for designing of new antidiabetic and anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, 12372, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh, 12372, Saudi Arabia.
- IMU Clinical School, Kluang, Kluang Johor, 86000, Malaysia.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh, 12372, Saudi Arabia.
ORCID-Profile: Ahmed Bari
Förderung
- Deputyship for Research and Innovation, "Ministry of Education" in Saudi Arabia
Zitieren
APA
Ghani, U., Syed, S. A., Aljunidel, S., Khan, A. A., Nur-E-Alam, M., AlNoshan, A., Al-Rehaily, A. J., AlObaid, A., & Bari, A. (2024). Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents. Chemistry & Biodiversity, 21(5). https://doi.org/10.1002/cbdv.202301399
Vancouver
Ghani U, Syed SA, Aljunidel S, Khan AA, Nur-E-Alam M, AlNoshan A, et al. Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents. Chemistry & Biodiversity. 2024;21(5). doi:10.1002/cbdv.202301399
BibTeX
@article{Ghani2024,
author = {Ghani, Usman and Syed, Saeed Ali and Aljunidel, Sarah and Khan, Anis Ahmad and Nur-E-Alam, Mohammad and AlNoshan, Abdulrahman and Al-Rehaily, Adnan J and AlObaid, Abdulrahman and Bari, Ahmed},
title = {Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents},
journal = {Chemistry & Biodiversity},
year = {2024},
volume = {21},
number = {5},
doi = {10.1002/cbdv.202301399}
}
EUVIMED